ClinVar Miner

Submissions for variant NM_001082971.2(DDC):c.1040G>A (p.Arg347Gln)

gnomAD frequency: 0.00003  dbSNP: rs201951824
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Centogene AG - the Rare Disease Company RCV000184027 SCV001424401 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000184027 SCV001983524 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase 2021-09-15 criteria provided, single submitter clinical testing Variant summary: DDC c.1040G>A (p.Arg347Gln) results in a conservative amino acid change located in the Pyridoxal phosphate-dependent transferase, major domain (IPR015421) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 249548 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in DDC causing Deficiency Of Aromatic-L-Amino-Acid Decarboxylase (4.8e-05 vs 0.0011), allowing no conclusion about variant significance. c.1040G>A has been reported in the literature in multiple individuals affected with Deficiency Of Aromatic-L-Amino-Acid Decarboxylase (example Veerbeek_2007, Kuster_2018, Dai_2019). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal decarboxylase activity towards L-Dopa substrate as observed by decreased steady state enzyme kinetic parameters (example, Montoli_2018). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.
Revvity Omics, Revvity RCV000184027 SCV002018152 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase 2022-06-28 criteria provided, single submitter clinical testing
DASA RCV000184027 SCV002061261 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase 2022-01-05 criteria provided, single submitter clinical testing The c.1040G>A;p.(Arg347Gln) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 202181; PMID: 26994895; 24865461; 30144970; 30952622) - PS4. Well-established in vitro or in vivo functional studies support a damaging effect on the gene or gene product (PMID: 24865461) - PS3_moderate. The variant is located in a mutational hot spot and/or critical and well-established functional domain (Pyridoxal_deC) - PM1. The variant is present at low allele frequencies population databases (rs201951824– gnomAD 0.0002629%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. Pathogenic missense variant in this residue have been reported (PMID: 26994895) - PM5. The variant co-segregated with disease in multiple affected family members (PMID: 30144970) - PP1. In summary, the currently available evidence indicates that the variant is pathogenic.
Invitae RCV000184027 SCV002230192 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase 2023-10-16 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 347 of the DDC protein (p.Arg347Gln). This variant is present in population databases (rs201951824, gnomAD 0.01%). This missense change has been observed in individual(s) with aromatic L-amino acid decarboxylase deficiency (PMID: 17240182, 23430870, 30144970). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 202181). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. For these reasons, this variant has been classified as Pathogenic.
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV002252027 SCV002523942 likely pathogenic See cases 2021-03-31 criteria provided, single submitter clinical testing ACMG classification criteria: PS3, PS4, PM2, PM3
Genetics and Molecular Pathology, SA Pathology RCV000184027 SCV002556698 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase 2022-05-11 criteria provided, single submitter clinical testing
GeneDx RCV003114340 SCV003798801 pathogenic not provided 2023-01-31 criteria provided, single submitter clinical testing Also observed with a second DDC variant in patients with AADC deficiency in published literature (Verbeek et al., 2007; Barth et al., 2012); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate severely reduced catalytic activity (Montioli et al., 2014; Montioli et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32369189, 17240182, 23430870, 20832343, 24865461, 26994895, 29356298, 30144970, 28100251, 31104889, 31975548, 27147232, 33763332, 32111562, 34426522, 34582790, 33083013)
Baylor Genetics RCV000184027 SCV003835548 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase 2022-10-23 criteria provided, single submitter clinical testing
Mendelics RCV000184027 SCV000236558 pathogenic Deficiency of aromatic-L-amino-acid decarboxylase 2013-08-28 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.